Zyprexa(Olanzapine)
Medicare prescription drug cost, prescriptions and prescribers, 2024
$12.4M
Medicare cost, 2024
$12.4M
Medicare cost, 2024
Medicare drug plans spent $12.4 million on Zyprexa (olanzapine) in 2024, for 8,883 prescriptions and refills filled by 1,208 patients. Spending fell 20% from 2023 to 2024. California accounts for the most spending ($1.7 million, 14% of the total).
Medicare cost, 2024
$12.4M
-20.2% from 2023
Prescriptions
8,883
$1,391.41 per claim
Patients
1,208
1,489 prescribers
Total spending
-
All plans
Questions and answers
How much does Medicare spend on Zyprexa?
Medicare prescription drug plans paid $12.4M for Zyprexa in 2024, for 8,883 prescriptions and refills to 1,208 patients (down 20.2% from 2023). The average cost per claim was $1,391.41.
Which state spends the most on Zyprexa?
California had the highest Medicare cost for Zyprexa in 2024: $1.7M for 1,120 claims, followed by New York ($1.2M).
Who prescribes Zyprexa the most?
Kairi Vaher, nurse practitioner in Pueblo, CO, had the highest Medicare cost for Zyprexa in 2024: 16 claims costing $53K.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Zyprexa, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Kairi Vaher Pueblo, CO | Nurse Practitioner | 16 | Under 11 | $53K |
| Jeffrey C Moffat Jr. San Bernardino, CA | Psychiatry | 22 | Under 11 | $50K |
| Sherryl J Rosen Lynn, MA | Certified Clinical Nurse Specialist | 24 | Under 11 | $48K |
| Ramon Martinez Orlando, FL | Psychiatry | 17 | Under 11 | $47K |
| Barry F Gritz Houston, TX | Psychiatry & Neurology | 25 | Under 11 | $43K |
| Gary D Riddle Newburgh, IN | Family Practice | 17 | Under 11 | $41K |
| Matthew J Pitera Toms River, NJ | Psychiatry | 17 | Under 11 | $39K |
| Maria Tsao Fairfax, VA | Psychiatry | 14 | Under 11 | $39K |
| Timothy C Liu San Diego, CA | Neuropsychiatry | 14 | Under 11 | $38K |
| Larry M Neuman New York, NY | Internal Medicine | 18 | Under 11 | $37K |
| Joseph R Miller Monona, WI | Nurse Practitioner | 13 | Under 11 | $35K |
| Wioletta Hryszan Mansfield Center, CT | Nurse Practitioner | 12 | Under 11 | $35K |
| Deborah B Fallon Cameron Park, CA | Nurse Practitioner | 13 | Under 11 | $34K |
| Aileen Wright Fort Collins, CO | Nurse Practitioner | 28 | Under 11 | $34K |
| Melissa A Virnig Baxter, MN | Nurse Practitioner | 26 | Under 11 | $34K |
| Stephanie Macdonald Mandan, ND | Nurse Practitioner | 12 | Under 11 | $34K |
| Vic A Linden New Orleans, LA | Psychiatry | 12 | Under 11 | $34K |
| Arnella Mikhaylova Jamaica, NY | Physician Assistant | 24 | Under 11 | $33K |
| Jeff Svoboda Sunnyvale, CA | Psychiatry | 30 | Under 11 | $32K |
| Lucille Venturanza Towanda, PA | Psychiatry | 25 | Under 11 | $32K |
| Erin Knight Woburn, MA | Nurse Practitioner | 13 | Under 11 | $31K |
| Nguyet B Le Anaheim, CA | Family Practice | 13 | Under 11 | $30K |
| Leah J Magnuson Grand Rapids, MI | Nurse Practitioner | 18 | Under 11 | $30K |
| Andrew Segraves Leawood, KS | Psychiatry | 23 | Under 11 | $30K |
| Gary B Fillette Pineville, LA | Psychiatry | 14 | Under 11 | $30K |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,756 | 11,469 | 1,390 | $16.0M |
| 2023 | 1,693 | 10,523 | 1,383 | $15.5M |
| 2024 | 1,489 | 8,883 | 1,208 | $12.4M |
Medicaid spending by quarter
Amount reimbursed by state Medicaid programs, all states
Amount reimbursed
Codes
- National drug codes (packages)
- 6
- RxNorm concept IDs
- 153046, 153047, 153048, 200034, 212405
- Application numbers
- NDA020592
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through June 2026, 108,127 side-effect reports named olanzapine, the active ingredient of Zyprexa (reports from 2003 on). 92,336 of them (85.4%) were serious, 13,205 named a death and 47,221 named a hospital stay. The reactions named most often were drug ineffective, weight increased and off label use. 32,831 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
108,127
7,455 in 2025 (+1.9% from 2024)
Serious
85.4%
92,336 reports
Deaths named
13,205
12.2% of reports
Hospital stays
47,221
43.7% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Zyprexa?
108,127 reports from 2003 through June 2026 named olanzapine, the active ingredient of Zyprexa. 92,336 of them (85.4%) were serious, 13,205 named a death and 47,221 named a hospital stay.
What are the most reported side effects of Zyprexa?
7,418 reports named drug ineffective, the reaction named most often, followed by weight increased (6,902) and off label use (6,239). In the last 5 years the reaction named most often was drug ineffective (3,182 reports). A report can name several reactions.
How many side-effect reports named Zyprexa in 2025?
7,455 reports were received in 2025 (+1.9% from 2024). 2026 so far: 3,448 reports through June 2026, and more keep arriving late.
Do side-effect reports prove that Zyprexa caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Zyprexa caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Other Medicare drug pages with olanzapine: Olanzapine, Olanzapine Odt, Zyprexa Zydis, Olanzapine*, Zyprexa*
- Makers on the stock market:
LLY·LLY drug pipeline - Drug approvals (28 approvals on file for olanzapine) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (olanzapine) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.